Call:+1 7755157689
October 10, 2025


Contact Us

Volume 14

Promotion of CO2 Assimilation by Stopping of Nox, NP Elimination is Easy Method to Stop Global Warming and to Get Fish for Long Life

1. Abstract Stop NOx elimination by ammonia. Stop water clean centre. Abandon bonfire inhibition rule. These 3 items are essential to promote CO2 assimilation to stop global warming stop.

Promotion of CO2 Assimilation by Stopping of Nox, NP Elimination is Easy Method to Stop Global Warming and to Get Fish for Long Life Read More »

A Case of Familial Partial Lipodystrophy Type 3 with A Novel Pparg Variant of Unknown Significance

1. Abstract Familial partial lipodystrophy (FPLD) is a heterogeneous group of rare genetic disorders (estimated prevalence <1/100,000) characterized by a lipodystrophy phenotype combined with metabolic abnormalities such as insulin resistance and hypertriglyceridemia. Several subtypes have been described

A Case of Familial Partial Lipodystrophy Type 3 with A Novel Pparg Variant of Unknown Significance Read More »

A Rare Case of Mid-Ventricular and Apical Hypertrophic Cardiomyopathy with Hourglass Appearance on Echocardiogram

1. Abstract Hypertrophic obstructive cardiomyopathy (HOCM) is a genetically driven cardiac condition most often involving asymmetric septal hypertrophy. Mid-ventricular and apical variants are rare, accounting for less than 5% of cases in Western populations, and present unique diagnostic and prognostic challenges.

A Rare Case of Mid-Ventricular and Apical Hypertrophic Cardiomyopathy with Hourglass Appearance on Echocardiogram Read More »

An Alternative Approach to Current Guidelines: The Use of Top-Up Long-Acting Buprenorphine Injection for A Patient Presenting with Withdrawal Symptoms

1. Abstract A 34-year-old male patient with opioid use disorder (OUD), who was transitioned from daily oral buprenorphine/naloxone therapy.

An Alternative Approach to Current Guidelines: The Use of Top-Up Long-Acting Buprenorphine Injection for A Patient Presenting with Withdrawal Symptoms Read More »

Efficacy of Pola-based Treatment in Treatment-Naive Diffuse Large B-Cell Lymphoma: A Real-World Analysis

1. Abstract Polatuzumab vedotin (Pola) has been approved in China as the first-line treatment in Diffuse Large B-Cell Lymphoma (DLBCL). This study aims to evaluate the efficacy of Pola-based therapy in DLBCL in the real-world, offering insights into treatment patterns and outcomes for newly diagnosed DLBCL in this population.

Efficacy of Pola-based Treatment in Treatment-Naive Diffuse Large B-Cell Lymphoma: A Real-World Analysis Read More »

Bronchoscopic Resection of Endotracheal Castleman Disease: A Rare Case Report

1. Abstract Castleman’s disease (CD) is an uncommon benign lymphoid hyperplasia, which was first reported by Benjamin Castleman in 1954. Pulmonary CD has been documented in the literature as a rare extranidal manifestation. We report a case of a 53-year-old woman with respiratory insufficiency presenting as an endotracheal lesion.

Bronchoscopic Resection of Endotracheal Castleman Disease: A Rare Case Report Read More »

You cannot copy content of this page